How gut cells sense different food components
Official title: Mechanisms of osmosensing in GI enteroendocrine cells
Funded at Mayo Clinic Rochester · NIH-10994977 · Data updated 2026-11-12
This study is looking at how certain cells in your gut react to different things in the food you eat, especially how they respond to changes in the concentration of substances, which can impact conditions like irritable bowel syndrome (IBS), to help find out if changing your diet, like trying a low FODMAP diet, can make you feel better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $49,174 |
| NIH project number | 1F30DK138638-01A1 |
| Project ID | NIH-10994977 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 years old who experience symptoms related to gastrointestinal disorders, particularly IBS.
✕Less likely to help
Patients with gastrointestinal disorders not related to osmolality or those who do not respond to dietary modifications may not benefit from this research.
What this research studies
This research investigates how gastrointestinal (GI) epithelial cells detect various components in the foods we eat, focusing on their ability to sense changes in osmolality, which can affect gut function. The study explores the role of enteroendocrine cells (EECs) in responding to both nutritive and non-nutritive stimuli, particularly in relation to conditions like irritable bowel syndrome (IBS). By understanding these mechanisms, the research aims to identify how dietary modifications, such as low FODMAP diets, can alleviate symptoms in patients with GI disorders. The approach includes examining the signaling pathways activated by different osmotic stimuli and their effects on GI motility.
Why it matters
Potential benefit: If successful, this research could lead to improved dietary recommendations and treatments for patients suffering from gastrointestinal disorders like IBS.
How similar studies have gone: Previous research has shown promising results in understanding the role of dietary components in managing GI disorders, suggesting that this approach could yield significant insights.
Where this research is happening
-
Mayo Clinic Rochester
Rochester, United States Active
Researchers
- Principal investigator: Bellampalli, Shreya — Mayo Clinic Rochester
- Study coordinator: Bellampalli, Shreya
Related research
Other NIH-funded projects on the same topics.
-
All of Us Biobank expansion and biospecimen program
A large Mayo Clinic–led project to collect and store biological samples from a diverse group of adults in the U.S. to advance precision medicine.
-
How baclofen and spinal cord stimulation interact in people with spinal cord injury
This study looks at how a common antispasmodic medicine (baclofen) works together with spinal cord stimulation in people who have spinal cord injuries and live with spasticity.
-
Pragmatic midodrine trial to reduce ICU vasopressor use in septic shock
A practical, patient-focused trial tests whether taking oral midodrine can lessen the need for IV vasopressors and shorten ICU stays for people with sepsis-related low blood pressure.
-
Estrogen’s role in eye pressure and glaucoma risk
A Mayo Clinic team is studying how estrogen and its receptors might control eye pressure in people with a common form of glaucoma.
-
Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms
A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.
-
ARTFL LEFFTDS Frontotemporal Dementia study cycle 2
This NIH grant supports a longitudinal study to understand and track frontotemporal lobar degeneration (FTLD) and related disorders in people, aiming to uncover biomarkers and disease progression information that could help patients and families.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.